These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1360888)

  • 61. Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.
    Mackay J; Elder PA; Porteous DJ; Steel CM; Hawkins RA; Going JJ; Chetty U
    Br J Cancer; 1988 Dec; 58(6):710-4. PubMed ID: 3066395
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence for a unifocal origin in familial ovarian cancer.
    Gallion HH; Guarino A; DePriest PD; van Nagell JR; Vaccarello L; Berek JS; Pieretti M
    Am J Obstet Gynecol; 1996 Apr; 174(4):1102-6; discussion 1106-8. PubMed ID: 8623836
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Loss of heterozygosity on chromosomes 1 and 11 in carcinoma of the pancreas.
    Ding SF; Habib NA; Delhanty JD; Bowles L; Greco L; Wood C; Williamson RC; Dooley JS
    Br J Cancer; 1992 Jun; 65(6):809-12. PubMed ID: 1352124
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Homozygosity of the short arm of chromosome 17 in cervical carcinoma.
    Russell SE; Lowry WS; Atkinson RJ; Hickey I
    Cancer Lett; 1992 Apr; 63(3):243-7. PubMed ID: 1349505
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Frequent loss of 11p13 and 11p15 loci in male germ cell tumours.
    Lothe RA; Hastie N; Heimdal K; Fosså SD; Stenwig AE; Børresen AL
    Genes Chromosomes Cancer; 1993 Jun; 7(2):96-101. PubMed ID: 7687459
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ha-ras polymorphisms in epithelial ovarian cancer.
    O'Briant K; Chrysson N; Hunter V; Tyson F; Tanner M; Daly L; George SL; Berchuck A; Soper J; Fowler W
    Gynecol Oncol; 1992 Jun; 45(3):299-302. PubMed ID: 1351862
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Functional complementation studies identify candidate genes and common genetic variants associated with ovarian cancer survival.
    Quaye L; Dafou D; Ramus SJ; Song H; Gentry-Maharaj A; Notaridou M; Hogdall E; Kjaer SK; Christensen L; Hogdall C; Easton DF; Jacobs I; Menon U; Pharoah PD; Gayther SA
    Hum Mol Genet; 2009 May; 18(10):1869-78. PubMed ID: 19270026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Distribution of Ha-ras alleles in patients with colorectal cancer and Crohn's disease.
    Klingel R; Mittelstaedt P; Dippold WG; Meyer zum Büschenfelde KH
    Gut; 1991 Dec; 32(12):1508-13. PubMed ID: 1685466
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Frequent occurrence of Ha-rasl allelic deletion in human ovarian adenocarcinomas.
    Viel A; De Pascale L; Toffoli G; Tumiotto L; Miotto E; Boiocchi M
    Tumori; 1991 Feb; 77(1):16-20. PubMed ID: 1708177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mutations in an alternatively spliced exon of h-ras are not associated with loss of heterozygosity on chromosome 11p15.5 in ovarian tumorigenesis.
    Friedman R; Velicescu M; Dubeau L
    Int J Oncol; 1992 Jul; 1(2):215-9. PubMed ID: 21584534
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Consensus report of the ESACP task force on standardization of diagnostic DNA image cytometry. European Society for Analytical Cellular Pathology.
    Böcking A; Giroud F; Reith A
    Anal Cell Pathol; 1995 Jan; 8(1):67-74. PubMed ID: 7734413
    [No Abstract]   [Full Text] [Related]  

  • 72. Grading of transitional cell bladder carcinoma by texture analysis of histological sections.
    Choi HK; Vasko J; Bengtsson E; Jarkrans T; Malmström PU; Wester K; Busch C
    Anal Cell Pathol; 1994 May; 6(4):327-43. PubMed ID: 8060889
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Application of multivariate, fuzzy set and neural network analysis in quantitative cytological examinations.
    Molnar B; Szentirmay Z; Bodo M; Sugar J; Feher J
    Anal Cell Pathol; 1993 May; 5(3):161-75. PubMed ID: 8343434
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Acute phase proteins as disease markers.
    Kushner I; Mackiewicz A
    Dis Markers; 1987 Mar; 5(1):1-11. PubMed ID: 2458880
    [No Abstract]   [Full Text] [Related]  

  • 75. Loss of cytokeratins in breast cancer cells using multiparameter DNA flow cytometry is related to both cellular factors and preparation procedure.
    Wingren S; Guerrieri C; Frånlund B; Stål O
    Anal Cell Pathol; 1995 Oct; 9(3):229-33. PubMed ID: 8562461
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Pathobiology of copper-induced injury in Bedlington terriers: ultrastructural and microanalytical studies.
    Haywood S; Fuentealba IC; Foster J; Ross G
    Anal Cell Pathol; 1996 May; 10(3):229-41. PubMed ID: 8798284
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantitative measurement of DNA content in gastric carcinoma; flow cytometry and video image analysis.
    Brito MJ; Rosa JC; Thomas VA; Filipe MI
    Anal Cell Pathol; 1994 Jul; 7(1):1-9. PubMed ID: 7981132
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Antibody directed enzyme prodrug therapy (ADEPT): a three phase system.
    Sharma SK; Bagshawe KD; Springer CJ; Burke PJ; Rogers GT; Boden JA; Antoniw P; Melton RG; Sherwood RF
    Dis Markers; 1991; 9(3-4):225-31. PubMed ID: 1813212
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Family and twin studies in systemic lupus erythematosus.
    Grennan DM; Parfitt A; Manolios N; Huang Q; Hyland V; Dunckley H; Doran T; Gatenby P; Badcock C
    Dis Markers; 1997 Apr; 13(2):93-8. PubMed ID: 9160184
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Myeloid cell differentiation in normal bone marrow and acute myeloid leukemia assessed by multi-dimensional flow cytometry.
    Terstappen LW; Loken MR
    Anal Cell Pathol; 1990 Jul; 2(4):229-40. PubMed ID: 1703434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.